These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 33007859)
1. Cholesterol Homeostasis: An In Silico Investigation into How Aging Disrupts Its Key Hepatic Regulatory Mechanisms. Morgan AE; Mc Auley MT Biology (Basel); 2020 Sep; 9(10):. PubMed ID: 33007859 [TBL] [Abstract][Full Text] [Related]
2. LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. Mc Auley MT; Mooney KM Med Hypotheses; 2017 Jul; 104():15-19. PubMed ID: 28673574 [TBL] [Abstract][Full Text] [Related]
3. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. Liu MX; Gao M; Li CZ; Yu CZ; Yan H; Peng C; Li Y; Li CG; Ma ZL; Zhao Y; Pu MF; Miao LL; Qi XM; Ren J Acta Pharmacol Sin; 2017 May; 38(5):660-671. PubMed ID: 28112179 [TBL] [Abstract][Full Text] [Related]
4. A whole-body mathematical model of cholesterol metabolism and its age-associated dysregulation. Mc Auley MT; Wilkinson DJ; Jones JJ; Kirkwood TB BMC Syst Biol; 2012 Oct; 6():130. PubMed ID: 23046614 [TBL] [Abstract][Full Text] [Related]
5. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia. Wu N; Sarna LK; Siow YL; O K Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122 [TBL] [Abstract][Full Text] [Related]
6. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion. Van Zuiden PE; Erickson SK; Cooper AD J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151 [TBL] [Abstract][Full Text] [Related]
7. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Ness GC; Chambers CM Proc Soc Exp Biol Med; 2000 May; 224(1):8-19. PubMed ID: 10782041 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
9. Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter. Zager RA; Johnson AC; Hanson SY Kidney Int; 2003 Jan; 63(1):123-33. PubMed ID: 12472775 [TBL] [Abstract][Full Text] [Related]
10. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160 [TBL] [Abstract][Full Text] [Related]
11. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Min HK; Kapoor A; Fuchs M; Mirshahi F; Zhou H; Maher J; Kellum J; Warnick R; Contos MJ; Sanyal AJ Cell Metab; 2012 May; 15(5):665-74. PubMed ID: 22560219 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL J Biol Chem; 2010 May; 285(19):14267-74. PubMed ID: 20231283 [TBL] [Abstract][Full Text] [Related]
13. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice. Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047 [TBL] [Abstract][Full Text] [Related]
14. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. Mistry P; Miller NE; Laker M; Hazzard WR; Lewis B J Clin Invest; 1981 Feb; 67(2):493-502. PubMed ID: 6257763 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis. Vaziri ND; Sato T; Liang K Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851 [TBL] [Abstract][Full Text] [Related]
16. Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding. Wu N; Sarna LK; Hwang SY; Zhu Q; Wang P; Siow YL; O K Biochim Biophys Acta; 2013 Oct; 1832(10):1560-8. PubMed ID: 23651731 [TBL] [Abstract][Full Text] [Related]
17. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274 [TBL] [Abstract][Full Text] [Related]
18. Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression. Leon C; Wasan KM; Sachs-Barrable K; Johnston TP Pharm Res; 2006 Jul; 23(7):1597-607. PubMed ID: 16783477 [TBL] [Abstract][Full Text] [Related]
19. Modulation by geraniol of gene expression involved in lipid metabolism leading to a reduction of serum-cholesterol and triglyceride levels. Galle M; Kladniew BR; Castro MA; Villegas SM; Lacunza E; Polo M; de Bravo MG; Crespo R Phytomedicine; 2015 Jul; 22(7-8):696-704. PubMed ID: 26141755 [TBL] [Abstract][Full Text] [Related]